title: Oral ketoconazole and miconazole vaginal pessary treatment for vaginal candidosis.
abstract: This prospective study was carried out on 250 patients having clinical and mycological evidence of vaginal candidosis. One hundred patients received ketoconazole orally (400 mg/day for 5 days), another 100 patients received miconazole vaginal pessary treatment (one 100 mg tablet locally for 14 days), while the other 50 patients received combination therapy of oral ketoconazole and miconazole vaginal tablets. Although all 3 regimens were significantly effective in relieving patients symptoms and physical signs, the combination therapy gave the best results. There was 98% symptomatic relief with the combination therapy in contrast to 82% and 78% in the oral ketocanozole and vaginal micronazole groups respectively (p less than 0.001). Mycological cure rates were also significantly higher in the combination therapy group (94% versus 80% and 76%). The relapse rate was least in the combination group 2% versus 8% and 12%. The combination therapy is recommended for the best results in vaginal candidosis.
authors.affiliation: Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi.
authors.forename: J B
authors.initials: JB
authors.lastname: Sharma
authors.forename: K
authors.initials: K
authors.lastname: Buckshee
authors.forename: N
authors.initials: N
authors.lastname: Gulati
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D010570:Pessaries; D011446:Prospective Studies; D012008:Recurrence
chemical_list: D008825:Miconazole; D007654:Ketoconazole